Endocrinology · Vasoactive Intestinal Peptide-Secreting Tumor

Acute Management and Stabilizing the Crisis

At a Glance

A VIPoma crisis is stabilized in the hospital with IV fluids and careful replacement of potassium and other electrolytes, often alongside short-acting octreotide to reduce diarrhea. Surgery usually waits until fluid balance, kidney function, and heart rhythm are stable.

When you are in a VIPoma crisis—often called WDHA syndrome—your body is in a state of extreme physiological stress ^[1]. The immediate priority of your medical team is not to remove the tumor, but to support your heart and kidneys from failing due to massive fluid and mineral loss ^[2].

Stabilization must happen first. Attempting surgery while your body is severely dehydrated or your potassium is dangerously low can lead to sudden drops in blood pressure during anesthesia ^[3]^[4].

The Stabilization Protocol: Emergency Rehydration

A VIPoma can force your body to lose a staggering amount of fluid per day through watery diarrhea, in severe cases reaching 3 to 11 liters ^[5]^[6]. This causes hypovolemic shock, where there is not enough blood volume for your heart to pump effectively ^[1].

In the hospital setting, depending on the severity of your symptoms, you will receive individualized care which may include:

Aggressive IV Fluids: You may require large volumes of intravenous fluids daily to keep up with your measured stool losses and support kidney function ^[1]^[7].
Careful Potassium Replacement: VIPoma causes the gut to “pump out” potassium. Your levels may drop to life-threatening lows (e.g., 2.4 mmol/L) ^[8]^[3]. You will likely receive potassium through an IV. In severe cases, this must be done slowly and under constant heart monitoring (ECG) ^[9]^[8].
Magnesium and Bicarbonate: Low magnesium often goes hand-in-hand with low potassium; if magnesium isn’t fixed, your potassium levels may not recover ^[10]. You may also be monitored for metabolic acidosis (excess acid in the blood) caused by the diarrhea; bicarbonate is reserved for selected severe cases ^[11]^[6]. Intensive care unit (ICU) admission and central lines are used when clinically indicated for severe instability.

Somatostatin Analogs: Targeting the Hormone

While fluids replace what you’ve lost, medications called Somatostatin Analogs (SSAs)—such as octreotide—are used to help stop the loss at its source ^[7].

These drugs bind to receptors on the VIPoma and signal it to reduce the release of the VIP hormone ^[12]^[13].

Rapid Action: In acute cases, doctors often use a short-acting, subcutaneous (under the skin) or intravenous version of octreotide ^[4].
Results: Patients frequently see a rapid reduction of diarrhea shortly after starting therapy ^[14]^[15]. However, the response can sometimes be partial, delayed, or require dose adjustments.
Monitoring: Clinicians will monitor your glucose, gastrointestinal effects, and ongoing stool output while adjusting the therapy ^[16]^[15].

Why Surgery Usually Must Wait

It may feel counterintuitive to leave a tumor in place during an emergency, but immediate surgery is generally considered unsafe during an acute secretory crisis ^[2].

The high levels of VIP in your blood can cause your blood vessels to dilate (widen) excessively ^[4]. If a surgeon begins an operation while these levels are high, your blood pressure could crash dangerously ^[4]. Furthermore, your heart is at high risk for arrhythmias (irregular beats) until your potassium and magnesium are fully restored ^[3].

Definitive treatments, like surgery or liver-directed therapy, are typically scheduled once you have “metabolic stability”—meaning your diarrhea is controlled, your fluids are balanced, and your electrolytes are steady ^[1]^[2]. Your care team will use this stabilization period to perform the advanced imaging needed to plan a safe and effective procedure ^[2]^[17].

Common questions in this guide

What happens first during a VIPoma crisis?

The medical team first replaces lost fluid and electrolytes and supports kidney function, blood pressure, and heart rhythm. Stabilization usually comes before tumor surgery because severe dehydration or low potassium can make anesthesia and an operation dangerous.

Why are potassium and magnesium monitored so closely in a VIPoma crisis?

Profuse watery diarrhea can cause potassium and magnesium levels to fall to dangerous levels. Replacing them carefully, sometimes through an IV with continuous heart-rhythm monitoring, helps reduce the risk of irregular heartbeats and severe muscle weakness.

How does octreotide help control VIPoma diarrhea?

Octreotide is a short-acting somatostatin analog that can signal the tumor to release less vasoactive intestinal peptide. This often reduces diarrhea quickly, although some people have a partial or delayed response and may need dose adjustments.

Why is surgery usually delayed during a VIPoma crisis?

Severe fluid loss, unstable electrolytes, and high vasoactive intestinal peptide levels can cause blood pressure to drop during anesthesia and increase the risk of abnormal heart rhythms. Doctors generally wait until diarrhea, fluid balance, kidney function, and electrolytes are stable enough for a safer procedure.

What symptoms should I report immediately during treatment for a VIPoma crisis?

Tell the medical team promptly about new heart palpitations, chest fluttering, profound muscle weakness, or ongoing large-volume watery diarrhea. These may signal continuing fluid or electrolyte loss and require immediate reassessment.

Get notified when new evidence is published on pancreatic vasoactive intestinal peptide producing tumor.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (17)

1
Metastatic mixed VIPoma/PPoma-induced diarrhoea causing renal failure.
Brown G, Monaghan AM, Fristedt R, et al.
Endocrinology, diabetes & metabolism case reports 2022; (2022()).
PMID: 36001009
2
Treatment options of metastatic and nonmetastatic VIPoma: a review.
Azizian A, König A, Ghadimi M
Langenbeck's archives of surgery 2022; (407(7)):2629-2636 doi:10.1007/s00423-022-02620-7.
PMID: 35931878
3
Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome.
Cavalli T, Giudici F, Santi R, et al.
Familial cancer 2016; (15(4)):645-9 doi:10.1007/s10689-016-9906-4.
PMID: 27071757
4
Perioperative Hypotensive Crisis in an Adolescent with a Pancreatic VIPoma and MEN1-Gene Variant.
Acosta-Gualandri A, Kao KT, Wong T, et al.
Hormone research in paediatrics 2019; (91(4)):285-289 doi:10.1159/000493396.
PMID: 30326482
5
Stereotactic Body Radiation Therapy Facilitating Debulking Surgery in Metastatic VIPoma with Severe Diarrhea and Hypovolemic Shock.
Wahab A, Raman P, Koshy M, Chen Y
The American journal of case reports 2025; (26()):e949041 doi:10.12659/AJCR.949041.
PMID: 40913783
6
Case Report: Irreversible Watery Diarrhea, Severe Metabolic Acidosis, Hypokalemia and Achloridria Syndrome Related to Vasoactive Intestinal Peptide Secreting Malignant Pheochromocytoma.
Negro A, Verzicco I, Tedeschi S, et al.
Frontiers in endocrinology 2021; (12()):652045 doi:10.3389/fendo.2021.652045.
PMID: 33815297
7
VIPoma: An Unusual Cause of Chronic Diarrhea.
Suteetorn S, Kitisin K, Wanpiyarat N, et al.
Acta medica (Hradec Kralove) 2024; (67(2)):64-68 doi:10.14712/18059694.2024.22.
PMID: 39434673
8
Secretory diarrhea and hypokalemia associated with colonic pseudo-obstruction: A case study and systematic analysis of the literature.
Bazerbachi F, Haffar S, Szarka LA, et al.
Neurogastroenterology and motility 2017; (29(11)) doi:10.1111/nmo.13120.
PMID: 28580600
9
Refractory diarrhea: A paraneoplastic syndrome of neuroblastoma.
Han W, Wang HM
World journal of gastroenterology 2015; (21(25)):7929-32 doi:10.3748/wjg.v21.i25.7929.
PMID: 26167095
10
Efficacy of Racecadotril in a Patient Affected by a Therapy-Refractory VIPoma and Carcinoid Syndrome.
Boesenkoetter J, Ellrichmann I, Konukiewitz B, et al.
JCEM case reports 2024; (2(10)):luae177 doi:10.1210/jcemcr/luae177.
PMID: 39351119
11
Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor.
Belei O, Basaca DG, Heredea ER, et al.
Life (Basel, Switzerland) 2023; (13(10)) doi:10.3390/life13101974.
PMID: 37895355
12
Efficacy of treatments for VIPoma: A GTE multicentric series.
Brugel M, Walter T, Goichot B, et al.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2021; (21(8)):1531-1539 doi:10.1016/j.pan.2021.08.001.
PMID: 34404601
13
Everolimus-induced somatostatin receptor overexpression in a rectal neuroendocrine tumor patient may promote somatostatin receptor-guided radionuclide therapy (peptide receptor radiotherapy) as an additional treatment option.
Mileva M, Wimana Z, Flamen P, Karfis I
World journal of nuclear medicine 2021; (20(3)):316-318 doi:10.4103/wjnm.WJNM_120_20.
PMID: 34703403
14
Octreotide reverses shock due to vasoactive intestinal peptide-secreting adrenal pheochromocytoma: A case report and review of literature.
Hu X, Cao W, Zhao M
World journal of clinical cases 2018; (6(14)):862-868 doi:10.12998/wjcc.v6.i14.862.
PMID: 30510956
15
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma.
Farina DA, Krogh KM, Boike JR
Case reports in gastroenterology 2019; (13(1)):225-229 doi:10.1159/000494554.
PMID: 31123451
16
Vasoactive Intestinal Peptide Tumor as the Cause of Persistent Diarrhea: A Diagnostic Challenge.
Lopes S, Alves M, Rodrigues P
Cureus 2022; (14(9)):e29130 doi:10.7759/cureus.29130.
PMID: 36258959
17
Clinical Characteristics and Management of Functional Pancreatic Neuroendocrine Neoplasms: A Single Institution 20-Year Experience with 286 Patients.
Qu Y, Li H, Wang X, et al.
International journal of endocrinology 2020; (2020()):1030518 doi:10.1155/2020/1030518.
PMID: 33204258

This page explains emergency stabilization of a VIPoma crisis for informational purposes only and does not replace urgent medical care or advice. Severe ongoing diarrhea, dehydration, palpitations, or weakness require immediate evaluation by a medical team.